Indonesia's First Botulinum Toxin Manufacturing Facility Officially Operates in Cikarang
PT Selatox Bio Pharma (Selatox) has officially opened its biopharmaceutical manufacturing facility in Cikarang, West Java, on Monday (20 July). The facility is claimed to be Indonesia’s first dedicated botulinum toxin manufacturing plant.
Selatox is a biopharmaceutical company focused on the research, development and manufacture of aesthetic biopharmaceutical products. The company is currently developing various products based on Botulinum Toxin Type A.
In addition, Selatox has obtained the Good Manufacturing Practice (CPOB) certification from the Food and Drug Supervisory Agency (BPOM) of the Republic of Indonesia.
BPOM Head Taruna Ikrar commended the achievement of PT Selatox Bio Pharma in securing the CPOB, or Good Manufacturing Practice (GMP), certificate.
“BPOM’s task is to safeguard and ensure that all products are safe and of good quality and efficacy,” he said at the Selatox Bio Pharma facility in Cikarang, West Java, on Monday (20 July).
According to Taruna, the facility’s operation is a strategic step in advancing the domestic biopharmaceutical industry, in line with soaring demand for biological products in the global market.
Taruna explained that biological products currently hold the largest share of the international pharmaceutical market. Global data shows that biological products account for around 65% of the total value of the pharmaceutical industry, while synthetic chemical-based products make up only about 35%.
“Currently, if we use the global market as our benchmark, 65% of the entire global market consists of biological products. Only 35% is chemical synthesis-based pharmaceutical products,” he explained.
Young Hoon, Chief Executive Officer of Selatox, said that obtaining CPOB certification from BPOM is an important achievement for the company. “This certification affirms that our manufacturing facility and quality management system have met the required standards,” he said.
“Going forward, we will continue to invest in the development of local human resources and the application of internationally standardised manufacturing technology, so that we can grow together and contribute to the advancement of Indonesia’s pharmaceutical and biotechnology industry,” he added.
Source: jawawa.id (https://jawawa.id/newsitem/indonesias-first-botulinum-toxin-manufacturing-facility-officially-operates-in-cikarang-1784620275)
Originally published by Media Indonesia (https://mediaindonesia.com/megapolitan/913002/pabrik-botulinum-toxin-pertama-di-indonesia-resmi-beroperasi-di-cikarang-selatox-peroleh-sertifikasi-cpob-dari-badan-pom), translated from Indonesian